Teligent

Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Called TICO, our strategy is focused on developing and selling pharmaceutical products in the Topical, Injectable, Complex and Ophthalmic markets.
Based in Buena, New Jersey, we have approximately 100 employees working at our 33,000 square-foot manufacturing and R&D complex. We are in the early stages of a significant expansion to our production facility that will include a sterile injectable manufacturing suite and an expanded footprint for the production of our topical products.
There are three pillars that shape our company. First, we are driven by impactful science. Second, we accept no middle ground when it comes to product quality. Finally, we believe in fostering a career of craftsmanship, where our people can become experts in their trade.
The spirit of our culture is to work hard, and be nice to people.

Company Growth (employees)
Type
Public
HQ
Vineland, US
Size (employees)
107 (est)
Teligent is headquartered in Vineland, US

Teligent Office Locations

Teligent has an office in Vineland
Vineland, US (HQ)
105 Lincoln Ave

Teligent Metrics

Teligent Financial Metrics

Market capitalization (23-May-2017)

$461.5 m

Closing share price (23-May-2017)

$8.7

Cash (31-Dec-2016)

$66 m
Teligent's current market capitalization is $461.5 m.
FY, 2015FY, 2016

Cash

$87.2 m$66 m

Accounts Receivable

$14 m$21.7 m

Inventories

$9 m$12.7 m

Current Assets

$116.8 m$103.3 m

PP&E

$8.7 m$26.2 m

Goodwill

$426 k$446 k

Total Assets

$184.8 m$183.2 m

Accounts Payable

$4 m$4.6 m

Current Liabilities

$10.8 m$15 m

Additional Paid-in Capital

$99.3 m$102.6 m

Retained Earnings

($32.9 m)($44.9 m)

Total Equity

$66.8 m$56.7 m

Financial Leverage

2.8 x3.2 x
FY, 2015FY, 2016

Net Income

$6.7 m($12 m)

Accounts Receivable

$1.3 m($7.7 m)

Inventories

($3.6 m)($5 m)

Accounts Payable

($2.8 m)$4.7 m

Cash From Operating Activities

($15.5 m)$1.1 m

Capital Expenditures

($6 m)($18.6 m)

Cash From Investing Activities

($53.1 m)($22 m)

Cash From Financing Activities

($3.1 m)($10 k)

Free Cash Flow

($9.5 m)$19.6 m
Y, 2016

Financial Leverage

3.2 x

Teligent Market Value History

Teligent Company Life

You may also be interested in